// App-Quantinova.ai

3250 : Associations of Clinical Outcomes after Allogeneic Hematopoietic Cell Transplantation with Number of Predicted Class II Restricted mHA

Researchers

Presenter

  • Othmane Jadi

Principal Investigators

  • Hancong Tang

  • Junke Wang

  • Dante Bortone

  • Steven Vensko

  • Loreall Pooler

  • Xin Sheng

  • Christopher A. Haiman

  • David Van Den Berg

  • Stephen R. Spellman

  • Marcelo C. Pasquini

  • Theresa E. Hahn

  • Paul M. Armistead

  • Benjamin G. Vincent

  • Lara E. Sucheston-Campbell

Medical Centers

  • UNC Chapel Hill School of Medicine, Chapel Hill, NC

  • College of Medicine, The Ohio State University, Columbus, OH

  • UNC Chapel Hill, Chapel Hill, NC

  • University of North Carolina, Chapel Hill, NC

  • University of Southern California, Los Angeles, CA

  • University of Southern California Keck School of Medicine, Los Angeles, CA

  • Department of Pediatrics, University of Southern California Keck School of Medicine, Los Angeles, CA

  • Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI

  • Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI

  • Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY

  • Lineberger Comprehensive Cancer Center at the University of North Carolina, Chapel Hill, NC

  • College of Veterinary Medicine, Cancer Prevention & Control, Columbus, OH

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Acute lymphoblastic leukemia

  • Alpha-thalassemia myelodysplasia syndrome

  • Acute myelocytic leukemia

  • Graft-versus-host disease

Biomarkers

  • Breakpoint Cluster Region

  • Gremlin 1

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved